rs3751667

Positions:

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_022773.4(LMF1):​c.306G>A​(p.Thr102=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.254 in 1,612,686 control chromosomes in the GnomAD database, including 56,067 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.29 ( 7115 hom., cov: 33)
Exomes 𝑓: 0.25 ( 48952 hom. )

Consequence

LMF1
NM_022773.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.13
Variant links:
Genes affected
LMF1 (HGNC:14154): (lipase maturation factor 1) Involved in triglyceride metabolic process. Predicted to be integral component of membrane. Predicted to be active in endoplasmic reticulum membrane. Implicated in familial lipase maturation factor 1 deficiency. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 16-954554-C-T is Benign according to our data. Variant chr16-954554-C-T is described in ClinVar as [Benign]. Clinvar id is 1246959.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-954554-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-1.13 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.422 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
LMF1NM_022773.4 linkuse as main transcriptc.306G>A p.Thr102= synonymous_variant 2/11 ENST00000262301.16 NP_073610.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
LMF1ENST00000262301.16 linkuse as main transcriptc.306G>A p.Thr102= synonymous_variant 2/115 NM_022773.4 ENSP00000262301 P1Q96S06-1

Frequencies

GnomAD3 genomes
AF:
0.289
AC:
43957
AN:
152038
Hom.:
7102
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.402
Gnomad AMI
AF:
0.319
Gnomad AMR
AF:
0.278
Gnomad ASJ
AF:
0.236
Gnomad EAS
AF:
0.406
Gnomad SAS
AF:
0.438
Gnomad FIN
AF:
0.130
Gnomad MID
AF:
0.244
Gnomad NFE
AF:
0.231
Gnomad OTH
AF:
0.277
GnomAD3 exomes
AF:
0.277
AC:
68629
AN:
247618
Hom.:
10548
AF XY:
0.280
AC XY:
37623
AN XY:
134596
show subpopulations
Gnomad AFR exome
AF:
0.406
Gnomad AMR exome
AF:
0.288
Gnomad ASJ exome
AF:
0.220
Gnomad EAS exome
AF:
0.407
Gnomad SAS exome
AF:
0.429
Gnomad FIN exome
AF:
0.139
Gnomad NFE exome
AF:
0.227
Gnomad OTH exome
AF:
0.258
GnomAD4 exome
AF:
0.250
AC:
365474
AN:
1460530
Hom.:
48952
Cov.:
37
AF XY:
0.255
AC XY:
184971
AN XY:
726506
show subpopulations
Gnomad4 AFR exome
AF:
0.415
Gnomad4 AMR exome
AF:
0.289
Gnomad4 ASJ exome
AF:
0.223
Gnomad4 EAS exome
AF:
0.392
Gnomad4 SAS exome
AF:
0.421
Gnomad4 FIN exome
AF:
0.152
Gnomad4 NFE exome
AF:
0.230
Gnomad4 OTH exome
AF:
0.263
GnomAD4 genome
AF:
0.289
AC:
44011
AN:
152156
Hom.:
7115
Cov.:
33
AF XY:
0.287
AC XY:
21343
AN XY:
74398
show subpopulations
Gnomad4 AFR
AF:
0.402
Gnomad4 AMR
AF:
0.278
Gnomad4 ASJ
AF:
0.236
Gnomad4 EAS
AF:
0.406
Gnomad4 SAS
AF:
0.437
Gnomad4 FIN
AF:
0.130
Gnomad4 NFE
AF:
0.231
Gnomad4 OTH
AF:
0.276
Alfa
AF:
0.246
Hom.:
7991
Bravo
AF:
0.301
Asia WGS
AF:
0.414
AC:
1441
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, criteria provided, single submitterclinical testingGeneDxAug 30, 2018- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsFeb 03, 2019This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.64
DANN
Benign
0.29

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3751667; hg19: chr16-1004554; COSMIC: COSV51897207; API